Search Results

Showing results 31-41 of 105 for 'Cancer'

  • 2016-05-acwis-enews-may-header-for-online-thumbnail
    Saving Your Skin: Melanoma Awareness

    We're looking forward to summer and basking in the sun, so it's a good thing that May is Melanoma/Skin Cancer Detection and Prevention Month! Awareness, protection, and early diagnosis are crucial; when melanoma does develop, it is hard to fight. That's why the Weizmann Institute of Science is shedding light on skin cancer from a number of fresh angles.

  • eran-hodis-tn
    Weizmann Alum Named to Forbes's ""30 Under 30"" List

    After earning his master's at Weizmann's Feinberg Graduate School, Eran Hodis, 29, discovered two of the most common genetic mutations in all of cancer. Now an MD-PhD candidate at Harvard and MIT, he credits Weizmann—and in particular, his mentors Profs. Eran Segal and Joel Sussman—with launching his scientific career.

  • May-Melanoma-2012-sstock_63014575-thumb
  • moshe-oren-tn
    The Moross Integrated Cancer Center at the Weizmann Institute of Science

    Seeing a clear need for a fresh approach to cancer research, the Weizmann Institute established the Moross Integrated Cancer Center (MICC). By collaborating with researchers and physicians; focusing on prevention, diagnosis, and treatment; and working to move therapies from the lab to the clinic, the MICC is a powerful new weapon in the war on cancer.

  • Mens-health-month-Fruit-sstock_80152498-thumb
    June is Men's Health Month

    Anchored by a Congressional program, Men's Health Month aims to heighten awareness of preventable health problems and encourage early detection and treatment. The Weizmann Institute is benefitting men's health in ways ranging from timely cancer diagnosis to to new insights into emotional behavior.

  • weizmann-views-moshe-oren-tn
    Using Basic Science to Advance Cancer Research

    Prof. Moshe Oren has spent decades studying the p53 gene, which plays a key role in keeping healthy cells from turning cancerous. His basic research has inspired other scientists to build on his findings, potentially leading to p53-based cancer treatments. As head of the Moross Integrated Cancer Center, Prof. Oren's knowledge will be more valuable than ever.

  • stop-prostate-cancer-tn
    Revolutionary Therapy for Prostate Cancer Coming to Europe

    Tookad, the prostate cancer treatment developed by Profs. Avigdor Scherz and Yoram Salomon, ""now is undergoing advanced trials in Israel and Europe,"" says Israel21c. Already approved for use in Mexico and on the verge of being more widely available, Tookad's efficacy for other cancers is now being tested in collaboration with Oxford University and Memorial Sloan Kettering.

  • p53 and Personalized Medicine

    Prof. Varda Rotter has devoted her career to a gene called p53—now known as the ""guardian of the genome"" because it protects us from developing cancer—and the possibility of tailor-made chemotherapy.

  • preventing-cancer-tn
    Preventing Cancer: The Weizmann Institute's Moross Integrated Cancer Center

    The Weizmann Institute of Science's Moross Integrated Cancer Center (MICC) aims to revolutionize cancer prevention, detection, and treatments. Several of the senior scientists involved with the MICC – Prof. Zvi Livneh, Prof. Moshe Oren, Dr. Tamar Paz-Elizur, Dr. Eran Elinav, and Dr. Ayelet Erez – discuss directions in cancer prevention research.